GUARDANT HEALTH INC (GH) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:GH • US40131M1099

104.635 USD
-0.39 (-0.38%)
Last: Feb 11, 2026, 01:45 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

Overall GH gets a fundamental rating of 3 out of 10. We evaluated GH against 102 industry peers in the Health Care Providers & Services industry. GH scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. While showing a medium growth rate, GH is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • GH had negative earnings in the past year.
  • GH had a negative operating cash flow in the past year.
  • In the past 5 years GH always reported negative net income.
  • In the past 5 years GH always reported negative operating cash flow.
GH Yearly Net Income VS EBIT VS OCF VS FCFGH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -200M -400M -600M

1.2 Ratios

  • The Return On Assets of GH (-31.23%) is worse than 82.35% of its industry peers.
Industry RankSector Rank
ROA -31.23%
ROE N/A
ROIC N/A
ROA(3y)-32.29%
ROA(5y)-25.29%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GH Yearly ROA, ROE, ROICGH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 -400 -600 -800 -1K

1.3 Margins

  • GH has a Gross Margin of 63.76%. This is amongst the best in the industry. GH outperforms 84.31% of its industry peers.
  • In the last couple of years the Gross Margin of GH has declined.
  • The Profit Margin and Operating Margin are not available for GH so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 63.76%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.32%
GM growth 5Y-1.93%
GH Yearly Profit, Operating, Gross MarginsGH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • GH does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for GH has been increased compared to 1 year ago.
  • GH has more shares outstanding than it did 5 years ago.
  • GH has a worse debt/assets ratio than last year.
GH Yearly Shares OutstandingGH Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
GH Yearly Total Debt VS Total AssetsGH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

  • GH has an Altman-Z score of 1.95. This is not the best score and indicates that GH is in the grey zone with still only limited risk for bankruptcy at the moment.
  • GH has a Altman-Z score (1.95) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 1.95
ROIC/WACCN/A
WACC8.74%
GH Yearly LT Debt VS Equity VS FCFGH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

  • GH has a Current Ratio of 3.50. This indicates that GH is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of GH (3.50) is better than 86.27% of its industry peers.
  • GH has a Quick Ratio of 3.12. This indicates that GH is financially healthy and has no problem in meeting its short term obligations.
  • GH's Quick ratio of 3.12 is amongst the best of the industry. GH outperforms 84.31% of its industry peers.
Industry RankSector Rank
Current Ratio 3.5
Quick Ratio 3.12
GH Yearly Current Assets VS Current LiabilitesGH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • The Earnings Per Share has been growing slightly by 1.21% over the past year.
  • GH shows a strong growth in Revenue. In the last year, the Revenue has grown by 30.38%.
  • The Revenue has been growing by 28.08% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)1.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%15.91%
Revenue 1Y (TTM)30.38%
Revenue growth 3Y25.52%
Revenue growth 5Y28.08%
Sales Q2Q%38.5%

3.2 Future

  • GH is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 18.49% yearly.
  • GH is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 27.88% yearly.
EPS Next Y39.51%
EPS Next 2Y13.83%
EPS Next 3Y15.82%
EPS Next 5Y18.49%
Revenue Next Year33.06%
Revenue Next 2Y30.19%
Revenue Next 3Y29.37%
Revenue Next 5Y27.88%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
GH Yearly Revenue VS EstimatesGH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 1B 2B 3B 4B
GH Yearly EPS VS EstimatesGH Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 5 -5

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • GH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for GH. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GH Price Earnings VS Forward Price EarningsGH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GH Per share dataGH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6

4.3 Compensation for Growth

  • GH's earnings are expected to grow with 15.82% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y13.83%
EPS Next 3Y15.82%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for GH!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

GUARDANT HEALTH INC

NASDAQ:GH (2/11/2026, 1:45:48 PM)

104.635

-0.39 (-0.38%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)10-29
Earnings (Next)02-19
Inst Owners97.26%
Inst Owner Change-1.24%
Ins Owners4.04%
Ins Owner Change-1.71%
Market Cap13.48B
Revenue(TTM)902.57M
Net Income(TTM)-398.79M
Analysts86.06
Price Target123.26 (17.8%)
Short Float %7.94%
Short Ratio4.75
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-1.57%
Min EPS beat(2)-2.26%
Max EPS beat(2)-0.89%
EPS beat(4)0
Avg EPS beat(4)-5.38%
Min EPS beat(4)-18.05%
Max EPS beat(4)-0.34%
EPS beat(8)1
Avg EPS beat(8)-3.14%
EPS beat(12)5
Avg EPS beat(12)4.15%
EPS beat(16)7
Avg EPS beat(16)3.82%
Revenue beat(2)2
Avg Revenue beat(2)7.96%
Min Revenue beat(2)6.68%
Max Revenue beat(2)9.24%
Revenue beat(4)4
Avg Revenue beat(4)5.45%
Min Revenue beat(4)1.97%
Max Revenue beat(4)9.24%
Revenue beat(8)8
Avg Revenue beat(8)5.72%
Revenue beat(12)11
Avg Revenue beat(12)4.58%
Revenue beat(16)13
Avg Revenue beat(16)3.54%
PT rev (1m)12.92%
PT rev (3m)77.92%
EPS NQ rev (1m)-5.06%
EPS NQ rev (3m)5.67%
EPS NY rev (1m)8.63%
EPS NY rev (3m)32.11%
Revenue NQ rev (1m)0.78%
Revenue NQ rev (3m)7.79%
Revenue NY rev (1m)0.17%
Revenue NY rev (3m)5.42%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 14.94
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-3.26
EYN/A
EPS(NY)-2.51
Fwd EYN/A
FCF(TTM)-2.04
FCFYN/A
OCF(TTM)-1.73
OCFYN/A
SpS7.01
BVpS-2.75
TBVpS-2.82
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -31.23%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 63.76%
FCFM N/A
ROA(3y)-32.29%
ROA(5y)-25.29%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.32%
GM growth 5Y-1.93%
F-Score5
Asset Turnover0.71
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 97.99%
Cap/Sales 4.36%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.5
Quick Ratio 3.12
Altman-Z 1.95
F-Score5
WACC8.74%
ROIC/WACCN/A
Cap/Depr(3y)115.32%
Cap/Depr(5y)203.86%
Cap/Sales(3y)8.54%
Cap/Sales(5y)12.91%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%15.91%
EPS Next Y39.51%
EPS Next 2Y13.83%
EPS Next 3Y15.82%
EPS Next 5Y18.49%
Revenue 1Y (TTM)30.38%
Revenue growth 3Y25.52%
Revenue growth 5Y28.08%
Sales Q2Q%38.5%
Revenue Next Year33.06%
Revenue Next 2Y30.19%
Revenue Next 3Y29.37%
Revenue Next 5Y27.88%
EBIT growth 1Y14.24%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year47.43%
EBIT Next 3Y25.17%
EBIT Next 5Y22.06%
FCF growth 1Y27.84%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y33.86%
OCF growth 3YN/A
OCF growth 5YN/A

GUARDANT HEALTH INC / GH FAQ

What is the ChartMill fundamental rating of GUARDANT HEALTH INC (GH) stock?

ChartMill assigns a fundamental rating of 3 / 10 to GH.


What is the valuation status for GH stock?

ChartMill assigns a valuation rating of 0 / 10 to GUARDANT HEALTH INC (GH). This can be considered as Overvalued.


What is the profitability of GH stock?

GUARDANT HEALTH INC (GH) has a profitability rating of 1 / 10.


Can you provide the financial health for GH stock?

The financial health rating of GUARDANT HEALTH INC (GH) is 4 / 10.